Simulating an Immune Response with a Combined Agent-Based Model of a Triple-Negative Breast Cancer Tumor and Vascular Network

被引:2
|
作者
Ventoso, Michael [1 ]
Norton, Kerri-Ann [1 ]
机构
[1] Bard Coll, Div Sci Math & Comp, Annandale On Hudson, NY 12504 USA
关键词
cancer; modeling; angiogenesis; T-cell; lymphocyte; MIGRATION; SURVIVAL;
D O I
10.1109/BIBM49941.2020.9313463
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Cytotoxic T-cells (CTLs) are one mechanism the immune system employs to eliminate cancer cells. In this study, we expand upon a previous 3-dimensional agent-based model of triple-negative breast cancer to include an immuno-therapy in the form of a CTL insertion into the tumor. The model consists of a triple-negative breast tumor, comprised of progenitor cells, cancer stem cells, tumor-associated macrophages, as well as an expanding vascular network. We investigate the treatment effects of inserting different numbers of CTLs into the tumor microenvironment, and their overall effect on tumor size in the short and longer terms. The results show that while CTLs decrease the size of the tumor they are ineffective at completely eliminating it, leading to continued tumor proliferation in the aftermath.
引用
收藏
页码:1303 / 1310
页数:8
相关论文
共 50 条
  • [31] Study on mouse model of triple-negative breast cancer: association between higher parity and triple-negative breast cancer
    Huang, Chun
    Wang, Xuan
    Sun, Baocun
    Li, Man
    Zhao, Xiulan
    Gu, Yanjun
    Cui, Yanfen
    Li, Yan
    TARGETED ONCOLOGY, 2015, 10 (01) : 85 - 97
  • [32] Identification of an immune classifier for predicting the prognosis and therapeutic response in triple-negative breast cancer
    Lin, Kuailu
    Gu, Qianyu
    Lai, Xixi
    BIOCELL, 2023, 47 (12) : 2681 - 2696
  • [33] Novel immune targets for the treatment of triple-negative breast cancer
    Corti, Chiara
    Nicolo, Eleonora
    Curigliano, Giuseppe
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2021, 25 (10) : 815 - 834
  • [34] Immune Checkpoint Blockade in Patients with Triple-Negative Breast Cancer
    Michel, Laura L.
    von Au, Alexandra
    Mavratzas, Athanasios
    Smetanay, Katharina
    Schuetz, Florian
    Schneeweiss, Andreas
    TARGETED ONCOLOGY, 2020, 15 (04) : 415 - 428
  • [35] BRCAness Phenotype and Immune Microenvironment in Triple-Negative Breast Cancer
    Ramos Navas, Luisa Ayelen
    Esquivel Vazquez, Beatriz
    Salido Ruiz, Eduardo
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 932 - 933
  • [36] Immune-related biomarkers in triple-negative breast cancer
    Zhang, Juan
    Tian, Qi
    Zhang, Mi
    Wang, Hui
    Wu, Lei
    Yang, Jin
    BREAST CANCER, 2021, 28 (04) : 792 - 805
  • [37] Opioids and immune checkpoint inhibitors differentially regulate a common immune network in triple-negative breast cancer
    Scarpa, Joseph R.
    Montagna, Giacomo
    Plitas, George
    Gulati, Amitabh
    Fischer, Gregory W.
    Mincer, Joshua S.
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [38] Immune Checkpoint Blockade in Patients with Triple-Negative Breast Cancer
    Laura L. Michel
    Alexandra von Au
    Athanasios Mavratzas
    Katharina Smetanay
    Florian Schütz
    Andreas Schneeweiss
    Targeted Oncology, 2020, 15 : 415 - 428
  • [39] Immune-related biomarkers in triple-negative breast cancer
    Juan Zhang
    Qi Tian
    Mi Zhang
    Hui Wang
    Lei Wu
    Jin Yang
    Breast Cancer, 2021, 28 : 792 - 805
  • [40] Analysis of circulating tumor cells for monitoring treatment response in triple-negative breast cancer
    Ramirez, Arturo
    Campton, Daniel
    Mahen, Elisabeth
    Blau, C. Anthony
    Kaldjian, Eric Peter
    Stilwell, Jackie L.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)